Literature DB >> 14514945

Altered tissue distribution in adults with cystic fibrosis.

C E Bolton1, A A Ionescu, W D Evans, R J Pettit, D J Shale.   

Abstract

BACKGROUND: Regional body composition was determined in adults with cystic fibrosis (CF). Our hypothesis was that dual energy x ray absorptiometry (DXA) scanning could assess the fat free mass, bone mineral content, and fat mass and determine the distribution of the changes.
METHOD: Height squared indices were derived for fat mass (FMI), fat free mass (FFMI), and bone mineral content (BMCI) of the arm, leg, and trunk by DXA in 51 patients and 18 age/sex matched healthy subjects.
RESULTS: The arm and leg FFMI in patients were less than in healthy controls (p<0.05); the deficit was leg>arm>trunk (-18.19%, -14.86%, +0.09%, p<0.02) and was related to severity of lung disease. Patients with a normal BMI and low total FFM (hidden loss) had a lower arm, leg and trunk FFMI than those with a normal BMI and total FFM (p<0.05). The BMCI for all body segments was lower in patients than in controls (p<0.001). The BMCI was lower in the leg and trunk (p<0.01) in patients with severe disease than in those with mild lung disease. In those with hidden FFM loss the BMCI was lower (p<0.05 in leg and trunk). There was no difference in the BMCI deficit between body segments. Fat mass in patients was not reduced.
CONCLUSION: Preferential loss of FFM is related to severity of lung disease and occurs in patients with a normal BMI. A similar loss of BMC occurs while FM is preserved. A hierarchical pattern of FFM loss of legs>arms>trunk was shown; BMC loss was evenly distributed.

Entities:  

Mesh:

Year:  2003        PMID: 14514945      PMCID: PMC1746496          DOI: 10.1136/thorax.58.10.885

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  28 in total

1.  Relationship of skeletal muscle mass, muscle strength and bone mineral density in adults with cystic fibrosis.

Authors:  S L Elkin; L Williams; M Moore; M E Hodson; O M Rutherford
Journal:  Clin Sci (Lond)       Date:  2000-10       Impact factor: 6.124

2.  Skeletal muscle weakness is associated with wasting of extremity fat-free mass but not with airflow obstruction in patients with chronic obstructive pulmonary disease.

Authors:  M P Engelen; A M Schols; J D Does; E F Wouters
Journal:  Am J Clin Nutr       Date:  2000-03       Impact factor: 7.045

3.  Skeletal muscle mass and muscle strength in relation to lower-extremity performance in older men and women.

Authors:  M Visser; D J Deeg; P Lips; T B Harris; L M Bouter
Journal:  J Am Geriatr Soc       Date:  2000-04       Impact factor: 5.562

4.  Bedside methods versus dual energy X-ray absorptiometry for body composition measurement in COPD.

Authors:  M C Steiner; R L Barton; S J Singh; M D L Morgan
Journal:  Eur Respir J       Date:  2002-04       Impact factor: 16.671

5.  Bone density, body composition, and inflammatory status in cystic fibrosis.

Authors:  A A Ionescu; L S Nixon; W D Evans; M D Stone; V Lewis-Jenkins; K Chatham; D J Shale
Journal:  Am J Respir Crit Care Med       Date:  2000-09       Impact factor: 21.405

6.  Pulmonary function, body composition, and protein catabolism in adults with cystic fibrosis.

Authors:  Alina A Ionescu; Lisette S Nixon; Stephen Luzio; Vanessa Lewis-Jenkins; William D Evans; Michael D Stone; David R Owens; Philip A Routledge; Dennis J Shale
Journal:  Am J Respir Crit Care Med       Date:  2002-02-15       Impact factor: 21.405

7.  Outcome of nutritional status and body composition of uremic patients on a very low protein diet.

Authors:  P Chauveau; N Barthe; V Rigalleau; S Ozenne; F Castaing; C Delclaux; V de Précigout; C Combe; M Aparicio
Journal:  Am J Kidney Dis       Date:  1999-09       Impact factor: 8.860

8.  Inflammatory response and body composition in chronic obstructive pulmonary disease.

Authors:  A A Eid; A A Ionescu; L S Nixon; V Lewis-Jenkins; S B Matthews; T L Griffiths; D J Shale
Journal:  Am J Respir Crit Care Med       Date:  2001-10-15       Impact factor: 21.405

9.  Midthigh muscle cross-sectional area is a better predictor of mortality than body mass index in patients with chronic obstructive pulmonary disease.

Authors:  Karine Marquis; Richard Debigaré; Yves Lacasse; Pierre LeBlanc; Jean Jobin; Guy Carrier; François Maltais
Journal:  Am J Respir Crit Care Med       Date:  2002-09-15       Impact factor: 21.405

10.  Altered body composition and muscle protein degradation in nutritionally growth-retarded children with cystic fibrosis.

Authors:  M Miller; L Ward; B J Thomas; W G Cooksley; R W Shepherd
Journal:  Am J Clin Nutr       Date:  1982-09       Impact factor: 7.045

View more
  8 in total

1.  Stimulated nitric oxide production and arginine deficiency in children with cystic fibrosis with nutritional failure.

Authors:  Mariëlle P K J Engelen; Gulnur Com; Yvette C Luiking; Nicolaas E P Deutz
Journal:  J Pediatr       Date:  2013-02-15       Impact factor: 4.406

2.  Body composition and nutritional intake in children with chronic kidney disease.

Authors:  Rajeeb Rashid; Esther Neill; Wilma Smith; Diane King; T James Beattie; Anna Murphy; Ian J Ramage; Heather Maxwell; S Faisal Ahmed
Journal:  Pediatr Nephrol       Date:  2006-09-05       Impact factor: 3.714

3.  New stable isotope method to measure protein digestibility and response to pancreatic enzyme intake in cystic fibrosis.

Authors:  M P K J Engelen; G Com; P J Anderson; N E P Deutz
Journal:  Clin Nutr       Date:  2013-11-09       Impact factor: 7.324

4.  Dose increase needed in most cystic fibrosis lung transplantation patients when changing from twice- to once-daily tacrolimus oral administration.

Authors:  Gustavo Adolfo Centeno Soto; Belén Ruiz-Antorán; Rosalía Laporta; Arantxa Sancho; María Teresa Lázaro; Concepción Payares Herrera; Isabel Salcedo; Maria Angeles Cos; Ferrán Torres; Piedad Usetti; Cristina Avendaño-Sola
Journal:  Eur J Clin Pharmacol       Date:  2015-05-09       Impact factor: 2.953

5.  Cardiovascular and musculskeletal co-morbidities in patients with alpha 1 antitrypsin deficiency.

Authors:  James M Duckers; Dennis J Shale; Robert A Stockley; Nichola S Gale; Bronwen A J Evans; John R Cockcroft; Charlotte E Bolton
Journal:  Respir Res       Date:  2010-12-07

6.  Body composition and pulmonary function in cystic fibrosis.

Authors:  Saba Sheikh; Babette S Zemel; Virginia A Stallings; Ronald C Rubenstein; Andrea Kelly
Journal:  Front Pediatr       Date:  2014-04-15       Impact factor: 3.418

7.  Lumacaftor/ivacaftor-associated health stabilisation in adults with severe cystic fibrosis.

Authors:  Susannah J King; Dominic Keating; Elyssa Williams; Eldho Paul; Brigitte M Borg; Felicity Finlayson; Brenda M Button; John W Wilson; Tom Kotsimbos
Journal:  ERJ Open Res       Date:  2021-02-01

8.  Measures of body habitus are associated with lung function in adults with cystic fibrosis: a population-based study.

Authors:  Doug L Forrester; Alan J Knox; Alan R Smyth; Andrew W Fogarty
Journal:  J Cyst Fibros       Date:  2012-09-05       Impact factor: 5.482

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.